157 related articles for article (PubMed ID: 12963029)
1. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines.
Shi C; Yu L; Yang F; Yan J; Zeng H
Biochem Biophys Res Commun; 2003 Sep; 309(3):578-83. PubMed ID: 12963029
[TBL] [Abstract][Full Text] [Related]
2. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells.
Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H
Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135
[TBL] [Abstract][Full Text] [Related]
3. [Induction of apoptosis in prostate cancer cell line PC-3 by BBSKE, a novel organoselenium compound, and its effect in vivo].
Shi CJ; Zeng HH; Li HW; Yang FG; Wu XQ; Yu LZ
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1984-8. PubMed ID: 14703435
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo.
Xing F; Li S; Ge X; Wang C; Zeng H; Li D; Dong L
Oral Oncol; 2008 Oct; 44(10):963-9. PubMed ID: 18282784
[TBL] [Abstract][Full Text] [Related]
5. A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells.
Peng ZF; Lan LX; Zhao F; Li J; Tan Q; Yin HW; Zeng HH
J Zhejiang Univ Sci B; 2008 Jan; 9(1):16-21. PubMed ID: 18196608
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of apoptosis induced by a novel thioredoxin reductase inhibitor in A549 cells: possible involvement of nuclear factor-kappaB-dependent pathway.
Lan L; Zhao F; Wang Y; Zeng H
Eur J Pharmacol; 2007 Jan; 555(2-3):83-92. PubMed ID: 17116300
[TBL] [Abstract][Full Text] [Related]
7. A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines.
Zhao F; Yan J; Deng S; Lan L; He F; Kuang B; Zeng H
Cancer Lett; 2006 May; 236(1):46-53. PubMed ID: 15982805
[TBL] [Abstract][Full Text] [Related]
8. Preparation of tri-block copolymer micelles loading novel organoselenium anticancer drug BBSKE and study of tissue distribution of copolymer micelles by imaging in vivo method.
Liu M; Fu J; Li J; Wang L; Tan Q; Ren X; Peng Z; Zeng H
Int J Pharm; 2010 May; 391(1-2):292-304. PubMed ID: 20211232
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest.
Fu JN; Li J; Tan Q; Yin HW; Xiong K; Wang TY; Ren XY; Zeng HH
Invest New Drugs; 2011 Aug; 29(4):627-36. PubMed ID: 20195699
[TBL] [Abstract][Full Text] [Related]
10. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen.
Zheng X; Chen Y; Bai M; Liu Y; Xu B; Sun R; Zeng H
Free Radic Biol Med; 2019 Feb; 131():7-17. PubMed ID: 30496814
[TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation.
Zheng X; Zhang Y; Zhang L; Xu W; Ma W; Sun R; Zeng H
Biomed Pharmacother; 2016 Oct; 83():212-220. PubMed ID: 27372405
[TBL] [Abstract][Full Text] [Related]
12. Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapy.
Wang L; Fu JN; Wang JY; Jin CJ; Ren XY; Tan Q; Li J; Yin HW; Xiong K; Wang TY; Liu XM; Zeng HH
Anticancer Drugs; 2011 Sep; 22(8):732-40. PubMed ID: 21562407
[TBL] [Abstract][Full Text] [Related]
13. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
Zhang H; Wu J; Yuan J; Li H; Zhang Y; Wu W; Chen W; Wang C; Meng S; Chen S; Huo M; He Y; Zhang C
J Exp Clin Cancer Res; 2021 Aug; 40(1):260. PubMed ID: 34412665
[TBL] [Abstract][Full Text] [Related]
14. Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model.
Ye SF; Li J; Ji SM; Zeng HH; Lu W
Acta Pharmacol Sin; 2017 Feb; 38(2):223-232. PubMed ID: 27917873
[TBL] [Abstract][Full Text] [Related]
15. Novel mechanism of ethaselen in poorly differentiated colorectal RKO cell growth inhibition: Simultaneous regulation of TrxR transcription, expression and enzyme activity.
Yin H; Li J; Xiong K; Wang L; Wang T; Tan Q; Fu J; Ren X; Zeng H
Differentiation; 2011 Jan; 81(1):49-56. PubMed ID: 20864247
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy.
He J; Li D; Xiong K; Ge Y; Jin H; Zhang G; Hong M; Tian Y; Yin J; Zeng H
Bioorg Med Chem; 2012 Jun; 20(12):3816-27. PubMed ID: 22579620
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of plasma thioredoxin reductase activity to growth of H22 hepatocellular carcinoma xenografts in Kunming mice].
Tan Q; Ren XY; Li J; Wang F; Deng SJ; Zeng HH
Ai Zheng; 2009 May; 28(5):472-7. PubMed ID: 19624873
[TBL] [Abstract][Full Text] [Related]
18. Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.
Zheng X; Ma W; Sun R; Yin H; Lin F; Liu Y; Xu W; Zeng H
Redox Biol; 2018 Apr; 14():237-249. PubMed ID: 28965082
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells.
Gan L; Yang XL; Liu Q; Xu HB
J Cell Biochem; 2005 Oct; 96(3):653-64. PubMed ID: 16088946
[TBL] [Abstract][Full Text] [Related]
20. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
